Stocks · Healthcare · Medical - Devices
Artivion, Inc. AORT
$22.31 +1.73% Close, Oct 2, 2026 · NYSE · Market cap $1.08B
Weak trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Net debt is 5.8× EBITDA, a high level of leverage.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -45.7%, behind the S&P 500 by 60.8 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
Growth32Weak
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 37%
- FCF growth (TTM, YoY)Bottom 3%
- Revenue growth, 3-year CAGRTop 46%
- Revenue growth accelerationBottom 39%
Quality48Neutral
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 35%
- Gross marginBottom 48%
- Operating marginTop 36%
- Accruals (lower is better)Bottom 35%
- Net debt / EBITDA (lower is better)Bottom 11%
- Interest coverTop 41%
Value75Positive
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 31%
- Free-cash-flow yieldTop 39%
- EBITDA / enterprise valueTop 26%
- Sales / enterprise valueTop 39%
Momentum9Very weak
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 12%
- 6-month returnBottom 13%
- 1-year return vs S&P 500Bottom 12%
- Distance from 52-week highBottom 25%
- Trend checklist (0–4)Bottom 14%
Revisions18Very weak
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 38%
- Upside to consensus price targetTop 39%
Stability64Neutral
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 22%
- Maximum drawdown, 3 yearsTop 31%
- Beta vs S&P 500 (lower is better)Top 26%
- Net debt / EBITDA (lower is better)Bottom 11%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 17.6% | 16.4% | ↓ |
| Gross margin | 64.0% | 62.8% | ↓ |
| Operating margin | 4.3% | 4.0% | ↓ |
| FCF margin | 1.9% | -2.3% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 16.4% | 17.6% | ↓ | Top 37% |
| Gross margin | 62.8% | 64.0% | ↓ | Bottom 48% |
| Operating margin | 4.0% | 4.3% | ↓ | Top 36% |
| Net margin | -0.7% | -4.4% | ↑ | — |
| Free-cash-flow margin | -2.3% | 1.9% | ↓ | — |
| Return on invested capital | -2.8% | — | Top 35% | |
| Revenue growth, 3-year CAGR | 12.0% | — | Top 46% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -4.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 3.5%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -7.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.76×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.04%
- Shareholder yield
- -1.04%
- Share count change, 1 year
- +7.0%
- Share count change, 3-year CAGR
- +6.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +0.9%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $42.50
- Target vs current price
- +90.5%
- Analysts with a rating
- 12
- Share rating Buy or Strong Buy
- 83%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -11300.0% | +1.5% | +9.4% | +0.6% | — |
| May 7, 2026 | -50.0% | +2.0% | -36.0% | -40.0% | -20.9% |
| Feb 12, 2026 | -63.6% | +1.4% | -5.2% | -9.8% | -36.6% |
| Nov 6, 2025 | +14.3% | +2.1% | +2.4% | -2.4% | -10.5% |
| Aug 7, 2025 | -72.5% | +1.3% | +35.5% | +36.4% | +41.5% |
| May 5, 2025 | -108.3% | +1.9% | +23.9% | +23.1% | +35.3% |
| Feb 24, 2025 | -3800.0% | -1.5% | -10.1% | -13.6% | +5.1% |
| Nov 7, 2024 | -266.7% | -1.6% | -7.6% | +0.1% | +7.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.28 | $0.00 | -11300.0% | $125.8M |
| May 7, 2026 | $0.03 | $0.06 | -50.0% | $116.3M |
| Feb 12, 2026 | $0.05 | $0.14 | -63.6% | $116.0M |
| Nov 6, 2025 | $0.16 | $0.14 | +14.3% | $113.4M |
| Aug 7, 2025 | $0.03 | $0.11 | -72.5% | $113.0M |
| May 5, 2025 | -$0.01 | $0.12 | -108.3% | $99.0M |
| Feb 24, 2025 | -$0.39 | -$0.01 | -3800.0% | $97.3M |
| Nov 7, 2024 | -$0.05 | $0.03 | -266.7% | $95.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 24.6× | — | — | Top 26% |
| EV / Sales | 3.00× | — | — | Top 39% |
| Free-cash-flow yield | -1.01% | — | — | Top 39% |
| Earnings yield | -0.33% | — | — | Top 31% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -0.3%
- 200-day average slope (20 days)
- -6.3%
- Distance from 50-day average
- -13.9%
- Distance from 200-day average
- -29.6%
- RSI (14)
- 33.5
- Relative volume
- 0.89×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 40.1%
- Volatility vs own 5-year history
- 43th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.67
- Correlation with S&P 500
- 0.22
- Current drawdown from 1-year high
- -53.2%
- Maximum drawdown, 3 years
- -57.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| May 6, 2021 | Oct 24, 2022 | -68.8% | 370 days | 677 days (Jul 9, 2025) |
| Nov 12, 2025 | Jun 12, 2026 | -57.8% | 145 days | Not yet recovered |
| Feb 24, 2021 | Mar 24, 2021 | -16.1% | 20 days | 26 days (Apr 30, 2021) |
| Oct 12, 2020 | Oct 30, 2020 | -15.7% | 14 days | 6 days (Nov 9, 2020) |
| Aug 22, 2025 | Sep 16, 2025 | -11.8% | 16 days | 30 days (Oct 28, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.08B
- EPS, diluted (TTM)
- -$0.07
- Revenue (TTM)
- $471.5M
- 52-week range
- $19.16 – $48.25
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $298.8M | $313.8M | $354.0M | $388.5M | $441.3M |
| Gross profit | $197.5M | $202.5M | $229.2M | $248.8M | $270.5M |
| Operating income | $8.1M | $6.2M | $5.7M | $38.9M | $26.7M |
| Net income | -$14.8M | -$19.2M | -$30.7M | -$13.4M | $9.8M |
| EPS (diluted) | -$0.38 | -$0.48 | -$0.75 | -$0.32 | $0.21 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $95.8M | $97.3M | $99.0M | $113.0M | $113.4M | $116.0M | $116.3M | $125.8M |
| Net income | -$2.3M | -$16.5M | -$505,000 | $1.3M | $6.5M | $2.4M | $1.4M | -$13.5M |
| EPS (diluted) | -$0.05 | -$0.39 | -$0.01 | $0.03 | $0.13 | $0.05 | $0.03 | -$0.28 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$2.6M | -$5.2M | $18.8M | $22.2M | $38.1M |
| Capital expenditure | -$13.1M | -$10.7M | -$7.4M | -$11.2M | -$39.0M |
| Free cash flow | -$15.7M | -$15.9M | $11.4M | $11.0M | -$911,000 |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$1.9M | -$1.8M | -$559,000 | $5.7M | $13.1M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $77.3M
- Total assets
- $1.07B
- Total liabilities
- $626.3M
- Total debt
- $408.0M
- Net debt
- $330.7M
- Shareholders’ equity
- $445.6M
As of Jun 30, 2026 (filed Aug 7, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Dec 9, 2015 | $0.03 | Dec 18, 2015 |
| Sep 9, 2015 | $0.03 | Sep 18, 2015 |
| Jun 10, 2015 | $0.03 | Jun 19, 2015 |
| Mar 11, 2015 | $0.03 | Mar 20, 2015 |
| Dec 10, 2014 | $0.03 | Dec 19, 2014 |
| Sep 10, 2014 | $0.03 | Sep 19, 2014 |
| Jun 11, 2014 | $0.03 | Jun 20, 2014 |
| Mar 12, 2014 | $0.03 | Mar 21, 2014 |
Short interest
- Shares sold short
- 3,284,198
- Days to cover
- 5.43
- Change vs previous report
- +12.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Dec 28, 2000
- 3-for-2
- Jul 1, 1996
- 2-for-1